TickerFactsScreenerDevelopers

INTEGRATED BIOPHARMA INC (INBP) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2017: $40.29M2018: $38.72M2019: $43.76M2020: $46.04M2021: $54.08M2022: $49.69M2023: $46.61M2024: $46.43M2025: $48.79M$48.79M
2017Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$48.79M+5.1%
2024$46.43M-0.4%
2023$46.61M-6.2%
2022$49.69M-8.1%
2021$54.08M+17.5%
2020$46.04M+5.2%
2019$43.76M+13.0%
2018$38.72M-3.9%
2017$40.29M—